| |
| |
|
| Insider
Information: |
Brockstedt Dirk G. |
| Relationship: |
|
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
152,423 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,148,725 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
152,423 |
|
|
| Total
Value |
$5,148,725 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -107.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
EVP of Research and Dev. |
2017-12-29 |
124,603 |
2015-11-16 |
0 |
Premium* |
|
|
Rapt Therapeutics, Inc. |
RAPT |
|
2024-01-05 |
27,820 |
2020-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-16 |
4 |
AS |
$27.50 |
$204,294 |
D/D |
(7,423) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-17 |
4 |
AS |
$27.78 |
$545,734 |
D/D |
(19,047) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-12-10 |
4 |
AS |
$29.43 |
$745,423 |
D/D |
(25,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-16 |
4 |
OE |
$0.45 |
$2,679 |
D/D |
5,953 |
7,423 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-05-15 |
4 |
AS |
$15.00 |
$148,155 |
D/D |
(9,877) |
10,256 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-08-17 |
4 |
AS |
$23.13 |
$236,328 |
D/D |
(9,877) |
10,256 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-11-02 |
4 |
AS |
$28.06 |
$53,595 |
D/D |
(1,910) |
10,256 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-11-16 |
4 |
AS |
$17.01 |
$168,008 |
D/D |
(9,877) |
10,256 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-12-16 |
4 |
OE |
$1.45 |
$17,400 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2016-01-11 |
4 |
AS |
$21.57 |
$479,015 |
D/D |
(22,000) |
12,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2016-05-16 |
4 |
AS |
$8.20 |
$7,421 |
D/D |
(905) |
12,000 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-01-06 |
4 |
AS |
$19.68 |
$23,203 |
D/D |
(1,179) |
17,556 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-01-05 |
4 |
AS |
$19.76 |
$16,225 |
D/D |
(821) |
18,735 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-01-03 |
4 |
D |
$36.73 |
$30,119 |
D/D |
(820) |
18,992 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-17 |
4 |
OE |
$0.45 |
$13,220 |
D/D |
19,047 |
19,047 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-01-05 |
4 |
S |
$21.97 |
$16,299 |
D/D |
(742) |
19,070 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-12-30 |
4 |
OE |
$6.18 |
$57,474 |
D/D |
9,300 |
19,556 |
0 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
AS |
$21.22 |
$209,590 |
D/D |
(9,877) |
19,812 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-05 |
4 |
AS |
$21.56 |
$44,931 |
D/D |
(2,084) |
19,812 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-11 |
4 |
AS |
$18.19 |
$48,167 |
D/D |
(2,648) |
19,812 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-11 |
4 |
AS |
$18.55 |
$49,102 |
D/D |
(2,647) |
19,812 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-07-12 |
4 |
AS |
$33.53 |
$88,787 |
D/D |
(2,648) |
19,812 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-08-11 |
4 |
AS |
$31.19 |
$82,560 |
D/D |
(2,647) |
19,812 |
0 |
% |
|
| RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-09-10 |
4 |
AS |
$35.78 |
$94,745 |
D/D |
(2,648) |
19,812 |
0 |
% |
|
86 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
